<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">24346917</article-id>
      <article-id pub-id-type="pmc">3875980</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20132500</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Sacroiliitis after use of oral isotretinoin - association
with acne fulminans or adverse effect?<xref ref-type="fn" rid="fn01">*</xref>
</article-title>
        <trans-title-group xml:lang="pt">
          <trans-title>Sacroile&#xED;te ap&#xF3;s uso de isotretino&#xED;na oral - associa&#xE7;&#xE3;o com acne
fulminans ou efeito adverso?</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Geller</surname>
            <given-names>Ariane Silva Bastos</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Alagia</surname>
            <given-names>Roberta Ferreira Nazareth</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> MD, PhD program student - Resident at Funda&#xE7;&#xE3;o de Dermatologia e Venereologia Alfredo da
Matta (FUAM) - Manaus (AM), Brazil.
.</aff>
      <aff id="aff02"><label>2</label> MD, residence in Dermatology - Funda&#xE7;&#xE3;o de Dermatologia e Venereologia Alfredo da Matta (FUAM) - Manaus (AM), Brazil
.</aff>
      <author-notes>
        <corresp id="c01"><bold>Mailing address:</bold> Ariane Silva Bastos Geller, Av Codaj&#xE1;s, 24 -
Cachoeirinha, 69.065-130 - Manaus - AM, Brazil. E-mail:
<email>arianegeller@hotmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2013</year>
      </pub-date>
      <volume>88</volume>
      <issue>6 Suppl 1</issue>
      <fpage>193</fpage>
      <lpage>196</lpage>
      <history>
        <date date-type="received">
          <day>30</day>
          <month>1</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>3</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2013 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Acne fulminans is a rare and severe form of acne that may evolve from acne vulgaris,
especially in male adolescents, or occur as an adverse effect of oral isotretinoin.
Arthritis is a serious clinical manifestation when the musculoskeletal system is
compromised by AF and has been reported as a rare adverse effect of isotretinoin.
Involvement of the sacroiliac joints occurs in 21% of acne fulminans cases. We
present the case of a 18-year-old male patient in whom acne fulminans evolved from
acne vulgaris grade IV and after inflammation resolution started treatment with oral
isotretinoin. Within a 30-day period of retinoid treatment he presented with back
pain followed by rapid, progressive inability to deambulate.</p>
      </abstract>
      <trans-abstract xml:lang="pt">
        <p>Acne fulminans &#xE9; uma forma grave e rara de acne que pode ser evolu&#xE7;&#xE3;o da acne vulgar,
principalmente em adolescentes do sexo masculino, ou ser precipitada durante o
tratamento com isotretino&#xED;na oral. A artrite pode ocorrer como grave complica&#xE7;&#xE3;o na
acne fulminans e j&#xE1; foi relatada como efeito adverso raro da isotretino&#xED;na. O
acometimento das articula&#xE7;&#xF5;es sacroil&#xED;acas ocorre em 21% das artrites associadas &#xE0;
acne fulminans. Relatase caso de paciente masculino, 18 anos, que desenvolveu acne
fulminans a partir de acne vulgar grau IV/conglobata e ap&#xF3;s resolu&#xE7;&#xE3;o do quadro
inflamat&#xF3;rio, foi iniciado tratamento da acne com isotretino&#xED;na. Com 30 dias de uso
do retin&#xF3;ide, o paciente iniciou dor lombar com piora r&#xE1;pida, progressiva que o
incapacitou de deambular.</p>
      </trans-abstract>
      <kwd-group>
        <kwd>Acne vulgaris</kwd>
        <kwd>Arthritis</kwd>
        <kwd>Isotretinoin</kwd>
        <kwd>Sacroiliitis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUCTION</title>
      <p>Isotretinoin is a safe and effective drug that has been used for over thirty years in
the treatment of acne. The more frequent adverse effects are related to skin and mucous
membranes.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>Arthralgias, and more rarely
sacroiliitis and polyneuropathy, signal musculoskeletal system involvement.<sup><xref ref-type="bibr" rid="r02">2</xref></sup>
</p>
      <p>Likewise, the acne fulminans (AF) described by Plewig and Kligman in 1975 is
characterized by sudden onset of ulcerous/crusted acne and systemic symptoms, including
fever and weight loss, osteoarticular signs and laboratory tests alterations. It can
also be triggered by isotretinoin and has sacroiliitis as a clinical manifestation.<sup><xref ref-type="bibr" rid="r01">1</xref>,<xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r03">3</xref></sup>This is the report of a
case of an adolescent who developed acne <italic>fulminans</italic> from grade IV acne
vulgaris, and after resolution of the inflammatory process, while initiating treatment
with oral isotretinoin, presented with bilateral sacroiliitis after 30 days of
treatment. The association of the retinoid with the clinical picture developed is
discussed in this report.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>An 18-year-old male patient had the onset of acne 3 years ago, with worsening in the 40
days that preceded the examination at the outpatient clinic. He presented fever and
arthralgias for 7 days, more intense on the sternal region and left shoulder, associated
with pustules and confluent nodules which formed crusted erythematous plaques in the
malar region, with formation of fistulous tracts in the bilateral mandibular region,
extending to the preauricular area with purulent secretion (<xref ref-type="fig" rid="f01">Figure 1</xref>). However, there were no thorax nor dorsum lesions.
Laboratory exams showed leucocytosis 22,640/mm<sup>3</sup> with 78.8% neutrophils,
without hepatic or lipid profile alterations. The drugs in use (topic betamethasone,
gentamicin and benzoyl peroxide) were suspended and dapsone 100mg/day and minocycline
100mg/day prescribed for 21 days. With the clinical improvement and normalization of the
hemogram, oral isotretinoin, 40mg/day (0.67mg/Kg/day) was prescribed. After 30 days
there was significant improvement of cutaneous lesions, with pustules more concentrated
on the perioral region, in addition to papules and erythema in the malar and mandibular
region, which already showed healing of the fistulous tracts (<xref ref-type="fig" rid="f02">Figure 2</xref>). At the same time, the patient reported intense lumbar
pain of quick progression, which prevented ambulation, resulting in hospitalization,
suspension of isotretinoin and use of analgesics and non-steroidal anti-inflammatory.
The lumbar spine radiography and MRI, performed during hospitalization, did not show
alterations that could explain the clinical condition. After hospital discharge, the
patient returned to the outpatient clinic using a wheelchair, and an orthopedic
evaluation was requested. The non-steroidal anti-inflammatory was continued and a bone
scintigraphy was requested. Bone scintigraphy, done after hospitalization, when the
patient was already walking with the aid of crutches, detected the radiopharmaceutical
trapped in the sacroiliac articulations, which was conclusive for light bilateral
sacroiliitis (<xref ref-type="fig" rid="f03">Figure 3</xref>). The HLA-B27 antigen was
negative. The patient maintained improvement of the articular condition, with
progressive recovery of ambulation after the use of orthesis and physical therapy. The
acne condition presented excellent results with the use of oral isotretinoin for 30 days
and after its suspension, benzoyl peroxide 5% associated with adapalene 0.1% and
intermittent oral antibiotic therapy, showing few inflammatory lesions and residual
erythema (<xref ref-type="fig" rid="f04">Figure 4</xref>).</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Presence of pustules, nodules and crusts on face, predominantly in the malar
region</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0193-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Improvement of condition 30 days after use of oral isotretinoin. A) presence
of pustules, erythema and papules; B) Pustules, erythema and fistulous
tract</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0193-g02"/>
      </fig>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>Bone scintigraphy showing light bilateral sacroiliitis (arrows)</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0193-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Patient under maintenance acne treatment with improvement of clinical
condition. A e B: presence of multiple scars</p>
        </caption>
        <graphic xlink:href="abd-88-06-s1-0193-g04"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Acne vulgaris, in all its clinical variables, involves 80% of young people and has in
acne <italic>fulminans</italic>, which affects 1% of this population, its most severe
form. It predominates in men between 13 and 22 years of age and is characterized by
abscesses, crusted hemorrhagic ulcerative lesions and purulent areas that invariably
involve the trunk with less intense facial involvement, associated with sudden systemic
manifestations like high fever, weight loss, asthenia, adenopathies and osteoarticular
involvement that affects mainly big articulations.<sup><xref ref-type="bibr" rid="r04">4</xref>,<xref ref-type="bibr" rid="r05">5</xref></sup>Clinically, it differs
from grade IV or conglobata acne, for even of the latter presents nodule-cystical
eruptive lesions, there is no systemic symptomatology. Laboratory exams show that with
acne <italic>fulminans </italic>there is evident leucocytosis, with left deviation and
increased erythrocyte sedimentation speed.<sup><xref ref-type="bibr" rid="r04">4</xref></sup>Despite the absence of extra-facial involvement in the reported patient, the
presence of signs and systemic symptoms of sudden onset accompanied by expressive
leucocytosis, besides the worsening and characteristics of the facial cutaneous lesions,
supported the diagnosis of acne <italic>fulminans</italic>. </p>
      <p>As previously mentioned, acne <italic>fulminans</italic> can involve the musculoskeletal
system and more commonly causes bone pain, arthralgias and arthritis. When accompanied
by arthritis, the sacroiliac articulations are involved in 21% of the cases reported on
the literature.<sup><xref ref-type="bibr" rid="r05">5</xref>,<xref ref-type="bibr" rid="r06">6</xref></sup>There are reports of acne <italic>fulminans</italic> caused by
isotretinoin, however in none of them it is related to the antigen HLA-B27.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup>
</p>
      <p>Oral isotretinoin is a drug largely employed in dermatology. This oral retinoid is
indicated for the treatment of grade III/nodular acne and grade IV/conglobata or
<italic>fulminans</italic> and presents as the most common adverse effect drying of
skin and mucous membranes.<sup><xref ref-type="bibr" rid="r01">1</xref></sup>Rare situations like
polyneuropathy and seronegative sacroiliitis can occur, as in the described case.<sup><xref ref-type="bibr" rid="r02">2</xref>,<xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref></sup>As a pathogenic
mechanism, it was suggested that isotretinoin could induce solubilization of the
liposomal membrane and consequently cytopathic destruction of the synovium, causing
arthritis as an adverse effect.<sup><xref ref-type="bibr" rid="r09">9</xref></sup>Ekisioglu and
others (2007) suggested that the positivity of antigen HLA-B27 renders the patient
susceptible to the development of sacroiliitis; however, the other cases described in
the literature do not corroborate this statement.<sup><xref ref-type="bibr" rid="r07">7</xref>,<xref ref-type="bibr" rid="r08">8</xref>,<xref ref-type="bibr" rid="r10">10</xref></sup>
</p>
      <p>In the case presented, bilateral sacroiliitis occurred only after the introduction of
oral isotretinoin, when the acne <italic>fulminans</italic> condition was resolved, with
normalized hemogram and clinical absence of inflammation. Based on the chronology of
events and expressive improvement of arthritis after suspension of oral isotretinoin, in
the described case the sacroiliitis was associated with the retinoid. However, it is
known that this type of clinical manifestation can occur late when associated with acne
<italic>fulminans</italic> and it is not possible to exclude this possibility.
Whatever the case, the investigation of rheumatological associations and careful
follow-up of patients that show osteoarticular involvement are indispensable, especially
in sacroiliitis, an arthritis that involves the axial skeleton and is thus considered
severe.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="fn01" fn-type="other">
        <label>*</label>
        <p>Work performed at Dermatology and Venereology Foundation Alfredo da Matta (FUAM) -
Manaus (AM), Brazil.</p>
      </fn>
      <fn id="fn02" fn-type="conflict">
        <p>Conflict of interest: None</p>
      </fn>
      <fn id="fn03" fn-type="financial-disclosure">
        <p>Financial Support: None</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES </title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Montagner</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Costa</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title xml:lang="pt">Diretrizes modernas no tratamento da acne vulgar
abordagem inicial &#xE0; manuten&#xE7;&#xE3;o dos benef&#xED;cios cl&#xED;nicos</article-title>
          <source>Surg Cosmet Dermatol</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>205</fpage>
          <lpage>213</lpage>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eksioglu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Oztekin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Unlu</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Cakci</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Keyik</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Karadavut</surname>
              <given-names>IK</given-names>
            </name>
          </person-group>
          <article-title>Sacroiliitis and polyneuropathy during isotretinoin
treatment</article-title>
          <source>Clin Exp Dermatol</source>
          <year>2007</year>
          <volume>33</volume>
          <fpage>122</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">17725657</pub-id>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Plewig</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Kligman</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <source>Acne: Morphogenesis and treatment</source>
          <publisher-loc>Berlin</publisher-loc>
          <publisher-name>Springer</publisher-name>
          <year>1975</year>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Romiti</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Jansen</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Plewig</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Acne fulminans</article-title>
          <source>An Bras Dermatol</source>
          <year>2000</year>
          <volume>75</volume>
          <fpage>611</fpage>
          <lpage>617</lpage>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zanelato</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>Gontijo</surname>
              <given-names>GM</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Pinto</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Cunha</surname>
              <given-names>PR</given-names>
            </name>
          </person-group>
          <article-title>Acne fulminans incapacitante</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>S9</fpage>
          <lpage>12</lpage>
          <pub-id pub-id-type="pmid">22068759</pub-id>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Knitzer</surname>
              <given-names>RH</given-names>
            </name>
            <name>
              <surname>Needleman</surname>
              <given-names>BW</given-names>
            </name>
          </person-group>
          <article-title>Musculoskeletal syndromes associated with
acne</article-title>
          <source>Semin Arthritis Rheum</source>
          <year>1991</year>
          <volume>20</volume>
          <fpage>247</fpage>
          <lpage>255</lpage>
          <pub-id pub-id-type="pmid">1828308</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bachmeyer</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Charoud</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Turc</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Callot</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Blum</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Aractingi</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Isotretinoin-induced bilateral
sacroiliitis</article-title>
          <source>Dermatology</source>
          <year>2003</year>
          <volume>206</volume>
          <fpage>285</fpage>
          <lpage>286</lpage>
          <pub-id pub-id-type="pmid">12673094</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Barbareschi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Paresce</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Chiaratti</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ferla Lodigiani</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Clerici</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Greppi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Unilateral sacroiliitis associated with systemic
isotretinoin treatment</article-title>
          <source>Int J Dermatol</source>
          <year>2010</year>
          <volume>49</volume>
          <fpage>331</fpage>
          <lpage>333</lpage>
          <pub-id pub-id-type="pmid">20465675</pub-id>
        </element-citation>
      </ref>
      <ref id="r09">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>De Francesco</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Stinco</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Campanella</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Acute arthritis during isotretinoin treatment for acne
conglobata</article-title>
          <source>Dermatology</source>
          <year>1997</year>
          <fpage>194</fpage>
          <lpage>195</lpage>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rozin</surname>
              <given-names>AP</given-names>
            </name>
            <name>
              <surname>Kagna</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Shiller</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Sacroiliitis and severe disability due to isotretinoin
therapy</article-title>
          <source>Rheumatol Int</source>
          <year>2010</year>
          <volume>30</volume>
          <fpage>985</fpage>
          <lpage>986</lpage>
          <pub-id pub-id-type="pmid">19533139</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
